CCNE1 and ovarian carcinoma: CCND, CCNE and E2F are over-expressed in a variety of cancer, including ovarian cancer (D′Andrilli et al, 2004), and data emanating from an immunohistochemical study of ovarian cancer (Hashiguchi et al, 2004) reveals alteration of G2 in ovarian cancer specimens.